Is Polycythemia Vera a Blood Cancer? What It Means

Yes, polycythemia vera (PV) is technically classified as a blood cancer, but it is vastly different from what most people picture when they hear that word. When a doctor says “cancer,” it is easy to assume you will need intensive treatments for a rapidly spreading disease. However, PV is a slow-growing blood cancer called a myeloproliferative neoplasm (MPN) ^[1]. It is managed more like a long-term, chronic illness than an acute cancer ^[2].

What Makes Polycythemia Vera a “Cancer”?

The word neoplasm means an abnormal, clonal proliferation of cells; in PV, this represents a malignant myeloid neoplasm of the blood-forming cells ^[1]. In a healthy body, blood cell production is tightly controlled. In PV, a genetic mutation in your bone marrow causes stem cells to continuously overproduce red blood cells, and often white blood cells and platelets ^[1].

In nearly all cases, this unchecked growth is driven by an acquired mutation in the JAK2 gene ^[3]. This means the mutation develops in your cells during your lifetime—it is generally not an inherited trait that you pass to your children, nor is it contagious ^[3]. Because this growth originates from a fundamental mutation within the bone marrow itself, it is distinct from conditions where high red blood cell counts are simply a temporary or secondary reaction to outside factors like smoking or sleep apnea ^[3]. PV does not form a solid tumor that is removed with surgery, and it is usually an indolent (slow-growing) condition ^[2].

Why Am I Not Getting Traditional Chemotherapy?

Traditional intensive chemotherapy is designed to quickly kill rapidly dividing cancer cells, aiming to completely eradicate a tumor or acute leukemia. Because medications have not been proven to completely cure PV or prevent it from eventually progressing, doctors generally do not use these harsh, systemic chemotherapy regimens because the severe risks outweigh the benefits for a chronic condition ^[4][5].

Instead, the goal of treatment is the long-term control of your blood counts to manage symptoms and prevent the most immediate dangers: serious blood clots (thrombosis) and bleeding ^[2][6]. To manage this risk, doctors aim to keep your hematocrit (the percentage of your blood made up of red cells) below a threshold, typically 45%, though your overall clot risk is also influenced by platelet counts, white cell counts, and inflammation ^[7][8].

Your care plan will likely involve a combination of:

• Phlebotomy: Having blood drawn periodically to physically remove excess red blood cells and lower blood volume ^[8].
• Low-Dose Aspirin: Used as a daily antiplatelet medication to further reduce the risk of blood clots ^[8]. Safety warning: Do not start taking over-the-counter aspirin without your hematologist’s explicit instruction. Aspirin can be unsafe if you have active bleeding, ulcers, or extreme platelet counts that paradoxically cause bleeding issues like acquired von Willebrand syndrome ^[9][10].
• Cytoreductive Therapy: While intensive chemotherapy is not used, some patients take medications to gently slow down the bone marrow’s production of blood cells ^[11]. This includes mild oral chemotherapy (like hydroxyurea), interferon injections, or targeted pills (like ruxolitinib) ^[12][5]. These are typically prescribed for “high-risk” patients—most commonly defined as being over age 60 or having a history of prior blood clots ^[13][14]—but they may also be used for severe symptoms or if phlebotomy alone cannot control counts.

Managing PV as a Chronic Illness

While PV is often manageable for years with appropriate treatment, it remains a serious medical condition requiring lifelong follow-up ^[4]. Over time, a small percentage of people with PV may experience disease progression into other bone marrow conditions, such as post-PV myelofibrosis (scarring of the bone marrow) or, rarely, acute myeloid leukemia ^[15].

It is vital to monitor your symptoms closely. Routine symptoms like fatigue, itching, headaches, and early fullness after eating (due to an enlarged spleen) should be tracked and discussed at your next hematology appointment ^[16][17].

Emergency Symptoms: PV carries a significant risk for serious cardiovascular and bleeding events ^[18][19]. Seek emergency medical care immediately if you experience:

• Sudden weakness, numbness (especially on one side of the face or body), or trouble speaking ^[18]
• Severe, sudden headache or vision loss ^[18]
• Chest pain or sudden shortness of breath ^[20][21]
• A painful, swollen, or red leg ^[21]
• Uncontrolled bleeding, vomiting blood, or black/tarry stools ^[19]

Living with polycythemia vera means balancing treatments to prevent clots and manage symptoms while monitoring for changes. By staying closely connected with your hematology team, you can actively manage your health and maintain your quality of life.